SPG21 Antikörper (C-Term)
Kurzübersicht für SPG21 Antikörper (C-Term) (ABIN6755545)
Target
Alle SPG21 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Marke
- IHC-plus™
-
Spezifität
- Human SPG21
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human SPG21 (Q9NZD8, NP_057714). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Marmoset, Bovine (100%), Monkey, Dog, Pig (92%), Opossum (86%), Mouse, Panda, Bat, Horse, Guinea pig (85%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Approved: IHC, IHC-P (10 μg/mL), WB (1 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- SPG21 (Spastic Paraplegia 21 (SPG21))
-
Andere Bezeichnung
- SPG21 / MAST
-
Hintergrund
-
Name/Gene ID: SPG21
Synonyms: SPG21, ACP33, Acid cluster protein 33, BM-019, Maspardin, GL010, MAST, Spastic paraplegia 21 protein -
Gen-ID
- 51324
-
NCBI Accession
- NP_057714
Target
-